JCR Pharmaceuticals Co (TSE:4552) Change In Receivables : 円0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is JCR Pharmaceuticals Co Change In Receivables?

JCR Pharmaceuticals Co's change in receivables for the quarter that ended in Dec. 2023 was 円0 Mil. It means JCR Pharmaceuticals Co's Accounts Receivable stayed the same from Sep. 2023 to Dec. 2023 .

JCR Pharmaceuticals Co's change in receivables for the fiscal year that ended in Mar. 2024 was 円0 Mil. It means JCR Pharmaceuticals Co's Accounts Receivable stayed the same from Mar. 2023 to Mar. 2024 .

JCR Pharmaceuticals Co's Accounts Receivable for the quarter that ended in Dec. 2023 was 円16,280 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. JCR Pharmaceuticals Co's Days Sales Outstanding for the three months ended in Dec. 2023 was 157.27.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. JCR Pharmaceuticals Co's liquidation value for the three months ended in Dec. 2023 was 円-5,901 Mil.

JCR Pharmaceuticals Co Change In Receivables Historical Data

The historical data trend for JCR Pharmaceuticals Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JCR Pharmaceuticals Co Change In Receivables Chart

JCR Pharmaceuticals Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

Get a 7-Day Free Trial

892.00

-204.00

-7,501.00

3,269.00

JCR Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

JCR Pharmaceuticals Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

JCR Pharmaceuticals Co (TSE:4552) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

JCR Pharmaceuticals Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	16280	/	9446	*	91
=	157.27

2. In Ben Graham's calculation of liquidation value, JCR Pharmaceuticals Co's accounts receivable are only considered to be worth 75% of book value:

JCR Pharmaceuticals Co's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	18301	-	46827	+	0.75 * 16280	+	0.5 * 20830
=	-5,901

JCR Pharmaceuticals Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of JCR Pharmaceuticals Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

JCR Pharmaceuticals Co (TSE:4552) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JCR Pharmaceuticals Co Ltd (TSE:4552) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

JCRRF:USA

Address

3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021

Website

http://www.jcrpharm.co.jp

JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.

JCR Pharmaceuticals Co (TSE:4552) Headlines

No Headlines